Compare TUYA & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TUYA | IRMD |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2021 | 2014 |
| Metric | TUYA | IRMD |
|---|---|---|
| Price | $1.78 | $94.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.49 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 1.2M | 120.8K |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | ★ 5.40% | 0.95% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 0.45 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | $13.76 | $12.38 |
| Revenue Next Year | $11.90 | $11.31 |
| P/E Ratio | ★ $27.45 | $205.24 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $1.81 | $55.11 |
| 52 Week High | $2.88 | $107.90 |
| Indicator | TUYA | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 32.95 | 57.71 |
| Support Level | N/A | $90.86 |
| Resistance Level | $2.48 | $97.63 |
| Average True Range (ATR) | 0.10 | 3.40 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 1.11 | 58.66 |
Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness. All the Group's revenue are derived from within the PRC.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.